Valuation GSK plc

Stocks

Real-time Estimate Cboe Europe 13:45:24 18/09/2026 BST			5-day change	1st Jan Change
1,882.00 ^GBX	-0.95%		+6.16%	+3.01%

09:05am	GSK plc : Deutsche Bank remains Neutral	ZD
09-17	GSK plc : UBS is Neutral	ZD

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	76,133	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	4.01%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	96,814	94,101	91,224
Change	-	-24.65%	-1.89%	-8.24%	28.83%	10.45%	-2.8%	-3.06%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	14.6x	12.1x	11.1x
PBR	5.34x	5.47x	4.4x	4.02x	4.51x	4.65x	4.08x	3.59x
PEG	-	0x	-0.2x	-0.4x	0x	-1.91x	0.6x	1.25x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.24x	2.14x	2.08x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.85x	2.65x	2.49x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.44x	7.67x	7.18x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.39x	8.52x	7.91x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	17.4x	16.2x	13.4x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	5.73%	6.15%	7.45%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6958	0.7494	0.7843
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.66%	3.94%	4.13%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.303	1.571	1.71
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	53.4%	47.7%	45.9%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,934	35,504	36,608
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,466	12,264	12,707
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,310	11,046	11,531
Net income ¹	4,385	14,956	4,928	2,575	5,716	5,348	6,284	6,856
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	20,681	17,968	15,091
Reference price ²	20.08	14.38	14.50	13.46	18.24	19.00	19.00	19.00
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	4,007,011	-	-
Announcement Date	09/02/22	01/02/23	31/01/24	05/02/25	04/02/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GSK PLC	14.58x	2.85x	8.44x	3.66%	102B
ELI LILLY AND COMPANY	32.77x	11.91x	24.15x	0.6%	1,027B
JOHNSON & JOHNSON	30.06x	6.68x	18.71x	1.99%	651B
ABBVIE INC.	33.39x	7.81x	16.15x	2.6%	467B
ROCHE HOLDING AG	19.57x	4.78x	11.84x	2.77%	350B
NOVARTIS AG	19.88x	5.19x	12.87x	3.09%	268B
ASTRAZENECA PLC	21.24x	4.38x	12.5x	2.01%	257B
AMGEN INC.	24.06x	6.34x	11.29x	2.66%	205B
NOVO NORDISK A/S	12.43x	4.52x	9.45x	4.04%	190B
GILEAD SCIENCES, INC.	-45.64x	6.64x	25.94x	2.18%	187B
Average	16.23x	6.11x	15.13x	2.56%	370.38B
Weighted average by Cap.	23.40x	7.59x	17.59x	2.03%